HEADER TRANSFERASE 14-DEC-22 8BZJ TITLE HUMAN MST3 (STK24) KINASE IN COMPLEX WITH INHIBITOR MRLW5 COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE/THREONINE-PROTEIN KINASE 24; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: MAMMALIAN STE20-LIKE PROTEIN KINASE 3,MST-3,STE20-LIKE COMPND 5 KINASE MST3; COMPND 6 EC: 2.7.11.1; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: STK24, MST3, STK3; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS SELECTIVE KINASE INHIBITORS, STRUCTURE-BASED DRUG DESIGN, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR D.I.BALOURDAS,M.RAK,R.TESCH,S.KNAPP,A.C.JOERGER,STRUCTURAL GENOMICS AUTHOR 2 CONSORTIUM (SGC) REVDAT 3 19-JUN-24 8BZJ 1 JRNL REVDAT 2 24-MAY-23 8BZJ 1 FORMUL REVDAT 1 18-JAN-23 8BZJ 0 JRNL AUTH M.RAK,A.MENGE,R.TESCH,L.M.BERGER,D.I.BALOURDAS,E.SHEVCHENKO, JRNL AUTH 2 A.KRAMER,L.ELSON,B.T.BERGER,I.ABDI,L.M.WAHL,A.POSO,A.KAISER, JRNL AUTH 3 T.HANKE,T.KRONENBERGER,A.C.JOERGER,S.MULLER,S.KNAPP JRNL TITL DEVELOPMENT OF SELECTIVE PYRIDO[2,3- D ]PYRIMIDIN-7(8 H JRNL TITL 2 )-ONE-BASED MAMMALIAN STE20-LIKE (MST3/4) KINASE INHIBITORS. JRNL REF J.MED.CHEM. V. 67 3813 2024 JRNL REFN ISSN 0022-2623 JRNL PMID 38422480 JRNL DOI 10.1021/ACS.JMEDCHEM.3C02217 REMARK 2 REMARK 2 RESOLUTION. 2.52 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.10.1_2155 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.52 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 39.05 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 2.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.7 REMARK 3 NUMBER OF REFLECTIONS : 22195 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.185 REMARK 3 R VALUE (WORKING SET) : 0.182 REMARK 3 FREE R VALUE : 0.250 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.677 REMARK 3 FREE R VALUE TEST SET COUNT : 1038 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 39.0500 - 4.8181 0.98 3035 141 0.1623 0.1951 REMARK 3 2 4.8181 - 3.8253 0.97 3075 90 0.1465 0.2118 REMARK 3 3 3.8253 - 3.3421 0.98 3010 159 0.1773 0.2369 REMARK 3 4 3.3421 - 3.0366 0.98 2891 262 0.2301 0.3246 REMARK 3 5 3.0366 - 2.8190 0.98 3063 126 0.2381 0.3054 REMARK 3 6 2.8190 - 2.6529 0.98 3049 115 0.2397 0.3228 REMARK 3 7 2.6529 - 2.5200 0.98 3034 145 0.2532 0.3269 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.350 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 27.772 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 55.75 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 57.92 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 4180 REMARK 3 ANGLE : 0.962 5701 REMARK 3 CHIRALITY : 0.052 657 REMARK 3 PLANARITY : 0.006 783 REMARK 3 DIHEDRAL : 12.691 2529 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8BZJ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 15-DEC-22. REMARK 100 THE DEPOSITION ID IS D_1292127356. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 14-MAY-21 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06DA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 22207 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.520 REMARK 200 RESOLUTION RANGE LOW (A) : 48.660 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.8 REMARK 200 DATA REDUNDANCY : 3.400 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.52 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.62 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.8 REMARK 200 DATA REDUNDANCY IN SHELL : 3.50 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.51 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PROTEIN SOLUTION: 11 MG/ML MST3 IN 25 REMARK 280 MM HEPES PH 7.5, 200 MM NACL, 0.5 MM TCEP, 5% GLYCEROL, WITH 1 REMARK 280 MM INHIBITOR). CRYSTALLIZATION BUFFER: 12% PEG 6000, 0.1 M HEPES REMARK 280 PH 7.4., VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 3 REMARK 465 ARG A 4 REMARK 465 ALA A 5 REMARK 465 GLN A 6 REMARK 465 LEU A 7 REMARK 465 TRP A 8 REMARK 465 GLY A 9 REMARK 465 LEU A 10 REMARK 465 ALA A 11 REMARK 465 LEU A 12 REMARK 465 ASN A 13 REMARK 465 LYS A 14 REMARK 465 ARG A 15 REMARK 465 ARG A 16 REMARK 465 ALA A 17 REMARK 465 THR A 18 REMARK 465 LEU A 19 REMARK 465 PRO A 20 REMARK 465 HIS A 21 REMARK 465 PRO A 22 REMARK 465 GLY A 23 REMARK 465 GLY A 24 REMARK 465 SER A 25 REMARK 465 GLY A 179 REMARK 465 GLN A 180 REMARK 465 LEU A 181 REMARK 465 THR A 182 REMARK 465 ASP A 183 REMARK 465 THR A 184 REMARK 465 GLN A 185 REMARK 465 ILE A 186 REMARK 465 LYS A 187 REMARK 465 ARG A 188 REMARK 465 ASN A 189 REMARK 465 THR A 190 REMARK 465 PHE A 191 REMARK 465 VAL A 192 REMARK 465 GLY A 193 REMARK 465 HIS A 307 REMARK 465 HIS A 308 REMARK 465 MET B 3 REMARK 465 ARG B 4 REMARK 465 ALA B 5 REMARK 465 GLN B 6 REMARK 465 LEU B 7 REMARK 465 TRP B 8 REMARK 465 GLY B 9 REMARK 465 LEU B 10 REMARK 465 ALA B 11 REMARK 465 LEU B 12 REMARK 465 ASN B 13 REMARK 465 LYS B 14 REMARK 465 ARG B 15 REMARK 465 ARG B 16 REMARK 465 ALA B 17 REMARK 465 THR B 18 REMARK 465 LEU B 19 REMARK 465 PRO B 20 REMARK 465 HIS B 21 REMARK 465 PRO B 22 REMARK 465 GLY B 23 REMARK 465 GLY B 24 REMARK 465 SER B 25 REMARK 465 GLY B 179 REMARK 465 GLN B 180 REMARK 465 LEU B 181 REMARK 465 THR B 182 REMARK 465 ASP B 183 REMARK 465 THR B 184 REMARK 465 GLN B 185 REMARK 465 ILE B 186 REMARK 465 LYS B 187 REMARK 465 ARG B 188 REMARK 465 ASN B 189 REMARK 465 THR B 190 REMARK 465 PHE B 191 REMARK 465 VAL B 192 REMARK 465 GLY B 193 REMARK 465 HIS B 306 REMARK 465 HIS B 307 REMARK 465 HIS B 308 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASN A 27 CG OD1 ND2 REMARK 470 LEU A 28 CG CD1 CD2 REMARK 470 LYS A 29 CG CD CE NZ REMARK 470 GLU A 33 CD OE1 OE2 REMARK 470 GLU A 34 CG CD OE1 OE2 REMARK 470 LYS A 41 CG CD CE NZ REMARK 470 LYS A 44 CG CD CE NZ REMARK 470 SER A 46 OG REMARK 470 LYS A 52 CE NZ REMARK 470 ARG A 57 CD NE CZ NH1 NH2 REMARK 470 GLU A 70 CG CD OE1 OE2 REMARK 470 GLU A 71 CG CD OE1 OE2 REMARK 470 ASP A 74 CG OD1 OD2 REMARK 470 LYS A 96 CD CE NZ REMARK 470 LYS A 103 CD CE NZ REMARK 470 ASP A 104 CG OD1 OD2 REMARK 470 GLU A 124 CG CD OE1 OE2 REMARK 470 LYS A 151 CD CE NZ REMARK 470 GLU A 166 CG CD OE1 OE2 REMARK 470 VAL A 177 CG1 CG2 REMARK 470 LYS A 204 CG CD CE NZ REMARK 470 GLN A 205 CG CD OE1 NE2 REMARK 470 SER A 206 OG REMARK 470 ARG A 226 NE CZ NH1 NH2 REMARK 470 LYS A 238 CG CD CE NZ REMARK 470 LYS A 282 CE NZ REMARK 470 LYS A 284 CD CE NZ REMARK 470 LYS A 291 CG CD CE NZ REMARK 470 LYS A 292 CG CD CE NZ REMARK 470 TYR A 295 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 GLU A 298 CG CD OE1 OE2 REMARK 470 HIS A 305 CG ND1 CD2 CE1 NE2 REMARK 470 HIS A 306 CG ND1 CD2 CE1 NE2 REMARK 470 LEU B 28 CG CD1 CD2 REMARK 470 LYS B 29 CG CD CE NZ REMARK 470 GLU B 34 CG CD OE1 OE2 REMARK 470 LYS B 41 CD CE NZ REMARK 470 LYS B 44 CG CD CE NZ REMARK 470 ARG B 57 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 60 NZ REMARK 470 GLU B 71 CG CD OE1 OE2 REMARK 470 GLU B 73 CG CD OE1 OE2 REMARK 470 ASP B 74 CG OD1 OD2 REMARK 470 GLU B 75 CG CD OE1 OE2 REMARK 470 GLN B 80 CG CD OE1 NE2 REMARK 470 GLN B 81 CG CD OE1 NE2 REMARK 470 SER B 87 OG REMARK 470 LYS B 96 CG CD CE NZ REMARK 470 GLU B 124 CG CD OE1 OE2 REMARK 470 LYS B 151 CG CD CE NZ REMARK 470 VAL B 177 CG1 CG2 REMARK 470 LYS B 204 CG CD CE NZ REMARK 470 GLN B 205 CG CD OE1 NE2 REMARK 470 SER B 206 OG REMARK 470 ARG B 226 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 238 CG CD CE NZ REMARK 470 LYS B 257 CG CD CE NZ REMARK 470 PHE B 273 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LYS B 282 CG CD CE NZ REMARK 470 LYS B 284 CG CD CE NZ REMARK 470 LYS B 291 CG CD CE NZ REMARK 470 LYS B 292 CG CD CE NZ REMARK 470 HIS B 304 CG ND1 CD2 CE1 NE2 REMARK 470 HIS B 305 CG ND1 CD2 CE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 39 -138.82 -115.61 REMARK 500 PHE A 47 -24.57 73.83 REMARK 500 ALA A 72 51.90 -162.89 REMARK 500 ASP A 104 -114.49 44.36 REMARK 500 ARG A 155 -0.84 80.06 REMARK 500 ASP A 156 52.91 -150.70 REMARK 500 LYS A 204 44.81 -71.70 REMARK 500 GLN A 205 42.90 0.18 REMARK 500 PRO A 230 154.39 -46.46 REMARK 500 LYS A 291 -166.88 -102.55 REMARK 500 LEU B 39 -140.06 -119.23 REMARK 500 ILE B 42 49.71 -100.81 REMARK 500 LYS B 44 -163.26 -70.62 REMARK 500 PHE B 47 -11.65 68.34 REMARK 500 GLN B 59 -0.16 74.32 REMARK 500 GLU B 71 35.17 -83.56 REMARK 500 GLU B 73 -73.41 -162.23 REMARK 500 ASP B 104 -122.54 56.48 REMARK 500 ARG B 155 -18.78 83.43 REMARK 500 LYS B 204 6.44 -62.29 REMARK 500 ASP B 209 -150.43 -121.49 REMARK 500 ASP B 209 -150.43 -121.49 REMARK 500 LEU B 267 62.63 -101.98 REMARK 500 LYS B 291 -169.25 -112.54 REMARK 500 REMARK 500 REMARK: NULL DBREF 8BZJ A 4 301 UNP Q9Y6E0 STK24_HUMAN 4 301 DBREF 8BZJ B 4 301 UNP Q9Y6E0 STK24_HUMAN 4 301 SEQADV 8BZJ MET A 3 UNP Q9Y6E0 INITIATING METHIONINE SEQADV 8BZJ ALA A 302 UNP Q9Y6E0 EXPRESSION TAG SEQADV 8BZJ HIS A 303 UNP Q9Y6E0 EXPRESSION TAG SEQADV 8BZJ HIS A 304 UNP Q9Y6E0 EXPRESSION TAG SEQADV 8BZJ HIS A 305 UNP Q9Y6E0 EXPRESSION TAG SEQADV 8BZJ HIS A 306 UNP Q9Y6E0 EXPRESSION TAG SEQADV 8BZJ HIS A 307 UNP Q9Y6E0 EXPRESSION TAG SEQADV 8BZJ HIS A 308 UNP Q9Y6E0 EXPRESSION TAG SEQADV 8BZJ MET B 3 UNP Q9Y6E0 INITIATING METHIONINE SEQADV 8BZJ ALA B 302 UNP Q9Y6E0 EXPRESSION TAG SEQADV 8BZJ HIS B 303 UNP Q9Y6E0 EXPRESSION TAG SEQADV 8BZJ HIS B 304 UNP Q9Y6E0 EXPRESSION TAG SEQADV 8BZJ HIS B 305 UNP Q9Y6E0 EXPRESSION TAG SEQADV 8BZJ HIS B 306 UNP Q9Y6E0 EXPRESSION TAG SEQADV 8BZJ HIS B 307 UNP Q9Y6E0 EXPRESSION TAG SEQADV 8BZJ HIS B 308 UNP Q9Y6E0 EXPRESSION TAG SEQRES 1 A 306 MET ARG ALA GLN LEU TRP GLY LEU ALA LEU ASN LYS ARG SEQRES 2 A 306 ARG ALA THR LEU PRO HIS PRO GLY GLY SER THR ASN LEU SEQRES 3 A 306 LYS ALA ASP PRO GLU GLU LEU PHE THR LYS LEU GLU LYS SEQRES 4 A 306 ILE GLY LYS GLY SER PHE GLY GLU VAL PHE LYS GLY ILE SEQRES 5 A 306 ASP ASN ARG THR GLN LYS VAL VAL ALA ILE LYS ILE ILE SEQRES 6 A 306 ASP LEU GLU GLU ALA GLU ASP GLU ILE GLU ASP ILE GLN SEQRES 7 A 306 GLN GLU ILE THR VAL LEU SER GLN CYS ASP SER PRO TYR SEQRES 8 A 306 VAL THR LYS TYR TYR GLY SER TYR LEU LYS ASP THR LYS SEQRES 9 A 306 LEU TRP ILE ILE MET GLU TYR LEU GLY GLY GLY SER ALA SEQRES 10 A 306 LEU ASP LEU LEU GLU PRO GLY PRO LEU ASP GLU THR GLN SEQRES 11 A 306 ILE ALA THR ILE LEU ARG GLU ILE LEU LYS GLY LEU ASP SEQRES 12 A 306 TYR LEU HIS SER GLU LYS LYS ILE HIS ARG ASP ILE LYS SEQRES 13 A 306 ALA ALA ASN VAL LEU LEU SER GLU HIS GLY GLU VAL LYS SEQRES 14 A 306 LEU ALA ASP PHE GLY VAL ALA GLY GLN LEU THR ASP THR SEQRES 15 A 306 GLN ILE LYS ARG ASN THR PHE VAL GLY THR PRO PHE TRP SEQRES 16 A 306 MET ALA PRO GLU VAL ILE LYS GLN SER ALA TYR ASP SER SEQRES 17 A 306 LYS ALA ASP ILE TRP SER LEU GLY ILE THR ALA ILE GLU SEQRES 18 A 306 LEU ALA ARG GLY GLU PRO PRO HIS SER GLU LEU HIS PRO SEQRES 19 A 306 MET LYS VAL LEU PHE LEU ILE PRO LYS ASN ASN PRO PRO SEQRES 20 A 306 THR LEU GLU GLY ASN TYR SER LYS PRO LEU LYS GLU PHE SEQRES 21 A 306 VAL GLU ALA CYS LEU ASN LYS GLU PRO SER PHE ARG PRO SEQRES 22 A 306 THR ALA LYS GLU LEU LEU LYS HIS LYS PHE ILE LEU ARG SEQRES 23 A 306 ASN ALA LYS LYS THR SER TYR LEU THR GLU LEU ILE ASP SEQRES 24 A 306 ALA HIS HIS HIS HIS HIS HIS SEQRES 1 B 306 MET ARG ALA GLN LEU TRP GLY LEU ALA LEU ASN LYS ARG SEQRES 2 B 306 ARG ALA THR LEU PRO HIS PRO GLY GLY SER THR ASN LEU SEQRES 3 B 306 LYS ALA ASP PRO GLU GLU LEU PHE THR LYS LEU GLU LYS SEQRES 4 B 306 ILE GLY LYS GLY SER PHE GLY GLU VAL PHE LYS GLY ILE SEQRES 5 B 306 ASP ASN ARG THR GLN LYS VAL VAL ALA ILE LYS ILE ILE SEQRES 6 B 306 ASP LEU GLU GLU ALA GLU ASP GLU ILE GLU ASP ILE GLN SEQRES 7 B 306 GLN GLU ILE THR VAL LEU SER GLN CYS ASP SER PRO TYR SEQRES 8 B 306 VAL THR LYS TYR TYR GLY SER TYR LEU LYS ASP THR LYS SEQRES 9 B 306 LEU TRP ILE ILE MET GLU TYR LEU GLY GLY GLY SER ALA SEQRES 10 B 306 LEU ASP LEU LEU GLU PRO GLY PRO LEU ASP GLU THR GLN SEQRES 11 B 306 ILE ALA THR ILE LEU ARG GLU ILE LEU LYS GLY LEU ASP SEQRES 12 B 306 TYR LEU HIS SER GLU LYS LYS ILE HIS ARG ASP ILE LYS SEQRES 13 B 306 ALA ALA ASN VAL LEU LEU SER GLU HIS GLY GLU VAL LYS SEQRES 14 B 306 LEU ALA ASP PHE GLY VAL ALA GLY GLN LEU THR ASP THR SEQRES 15 B 306 GLN ILE LYS ARG ASN THR PHE VAL GLY THR PRO PHE TRP SEQRES 16 B 306 MET ALA PRO GLU VAL ILE LYS GLN SER ALA TYR ASP SER SEQRES 17 B 306 LYS ALA ASP ILE TRP SER LEU GLY ILE THR ALA ILE GLU SEQRES 18 B 306 LEU ALA ARG GLY GLU PRO PRO HIS SER GLU LEU HIS PRO SEQRES 19 B 306 MET LYS VAL LEU PHE LEU ILE PRO LYS ASN ASN PRO PRO SEQRES 20 B 306 THR LEU GLU GLY ASN TYR SER LYS PRO LEU LYS GLU PHE SEQRES 21 B 306 VAL GLU ALA CYS LEU ASN LYS GLU PRO SER PHE ARG PRO SEQRES 22 B 306 THR ALA LYS GLU LEU LEU LYS HIS LYS PHE ILE LEU ARG SEQRES 23 B 306 ASN ALA LYS LYS THR SER TYR LEU THR GLU LEU ILE ASP SEQRES 24 B 306 ALA HIS HIS HIS HIS HIS HIS HET SJX A 401 32 HET SJX B 401 32 HET EDO B 402 4 HETNAM SJX 8-(4-AZANYLBUTYL)-6-[2-CHLORANYL-4-(6-METHYLPYRIDIN-2- HETNAM 2 SJX YL)PHENYL]-2-(METHYLAMINO)PYRIDO[2,3-D]PYRIMIDIN-7-ONE HETNAM EDO 1,2-ETHANEDIOL HETSYN EDO ETHYLENE GLYCOL FORMUL 3 SJX 2(C24 H25 CL N6 O) FORMUL 5 EDO C2 H6 O2 FORMUL 6 HOH *78(H2 O) HELIX 1 AA1 ASP A 31 LEU A 35 1 5 HELIX 2 AA2 GLU A 70 ASP A 74 5 5 HELIX 3 AA3 GLU A 75 GLN A 88 1 14 HELIX 4 AA4 LEU A 120 GLU A 124 5 5 HELIX 5 AA5 ASP A 129 GLU A 150 1 22 HELIX 6 AA6 LYS A 158 ALA A 160 5 3 HELIX 7 AA7 ALA A 199 LYS A 204 1 6 HELIX 8 AA8 SER A 210 GLY A 227 1 18 HELIX 9 AA9 HIS A 235 ASN A 246 1 12 HELIX 10 AB1 SER A 256 LEU A 267 1 12 HELIX 11 AB2 GLU A 270 ARG A 274 5 5 HELIX 12 AB3 THR A 276 LYS A 282 1 7 HELIX 13 AB4 HIS A 283 ALA A 290 1 8 HELIX 14 AB5 LYS A 292 SER A 294 5 3 HELIX 15 AB6 TYR A 295 HIS A 306 1 12 HELIX 16 AB7 ASP B 31 LEU B 35 1 5 HELIX 17 AB8 ASP B 74 GLN B 88 1 15 HELIX 18 AB9 LEU B 120 GLU B 124 5 5 HELIX 19 AC1 ASP B 129 GLU B 150 1 22 HELIX 20 AC2 LYS B 158 ALA B 160 5 3 HELIX 21 AC3 ALA B 199 LYS B 204 1 6 HELIX 22 AC4 SER B 210 GLY B 227 1 18 HELIX 23 AC5 HIS B 235 ASN B 246 1 12 HELIX 24 AC6 SER B 256 LEU B 267 1 12 HELIX 25 AC7 GLU B 270 ARG B 274 5 5 HELIX 26 AC8 THR B 276 LYS B 282 1 7 HELIX 27 AC9 HIS B 283 ALA B 290 1 8 HELIX 28 AD1 LYS B 292 TYR B 295 5 4 HELIX 29 AD2 LEU B 296 HIS B 304 1 9 SHEET 1 AA1 5 PHE A 36 LYS A 44 0 SHEET 2 AA1 5 GLU A 49 ASP A 55 -1 O ILE A 54 N THR A 37 SHEET 3 AA1 5 VAL A 61 ASP A 68 -1 O VAL A 62 N GLY A 53 SHEET 4 AA1 5 LYS A 106 GLU A 112 -1 O ILE A 109 N LYS A 65 SHEET 5 AA1 5 TYR A 97 LYS A 103 -1 N LYS A 103 O LYS A 106 SHEET 1 AA2 3 GLY A 117 SER A 118 0 SHEET 2 AA2 3 VAL A 162 LEU A 164 -1 O LEU A 164 N GLY A 117 SHEET 3 AA2 3 VAL A 170 LEU A 172 -1 O LYS A 171 N LEU A 163 SHEET 1 AA3 5 PHE B 36 LYS B 41 0 SHEET 2 AA3 5 GLU B 49 ASP B 55 -1 O LYS B 52 N LEU B 39 SHEET 3 AA3 5 VAL B 61 ASP B 68 -1 O VAL B 62 N GLY B 53 SHEET 4 AA3 5 LYS B 106 GLU B 112 -1 O MET B 111 N ALA B 63 SHEET 5 AA3 5 TYR B 97 LYS B 103 -1 N TYR B 101 O TRP B 108 SHEET 1 AA4 3 GLY B 117 SER B 118 0 SHEET 2 AA4 3 VAL B 162 LEU B 164 -1 O LEU B 164 N GLY B 117 SHEET 3 AA4 3 VAL B 170 LEU B 172 -1 O LYS B 171 N LEU B 163 CRYST1 55.049 57.737 61.771 88.86 89.18 62.12 P 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018166 -0.009610 -0.000118 0.00000 SCALE2 0.000000 0.019594 -0.000294 0.00000 SCALE3 0.000000 0.000000 0.016192 0.00000